{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-26-000085","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2026-07-02T14:10:31+00:00","discovered_at":"2026-07-02T14:11:00.386363+00:00","generated_at":"2026-07-02T14:11:05.581935+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Avanos receives all regulatory approvals for AIP acquisition; closing expected by July 27","bullets":["All required regulatory approvals received for acquisition by American Industrial Partners affiliates.","Transaction expected to close no later than July 27, 2026, subject to stockholder approval and other conditions.","Special stockholder meeting to approve the merger scheduled for July 22, 2026.","Avanos CEO David Pacitti and AIP Partner Joel Rotroff commented positively on the milestone."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-26-000085","json":"https://secwatch.observer/filing/0001606498-26-000085.json","markdown":"https://secwatch.observer/filing/0001606498-26-000085.md","text":"https://secwatch.observer/filing/0001606498-26-000085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000085/0001606498-26-000085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649826000085/avns-20260702.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T14:11:05.581935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}